TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $235,980 | +29.7% | 9,500 | -21.5% | 0.19% | +47.2% |
Q1 2023 | $181,984 | +44.9% | 12,100 | +14.0% | 0.13% | +46.0% |
Q4 2022 | $125,599 | +173.0% | 10,617 | -0.9% | 0.09% | +200.0% |
Q2 2022 | $46,000 | -64.6% | 10,717 | -21.7% | 0.03% | -64.6% |
Q1 2022 | $130,000 | -42.0% | 13,692 | +16.3% | 0.08% | -49.4% |
Q4 2021 | $224,000 | +89.8% | 11,772 | +166.0% | 0.16% | +70.5% |
Q3 2020 | $118,000 | – | 4,425 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |